Abstract
The African continent is poised to have a pivotal role in the global population landscape, with the United Nations projecting a population of 2.5 billion (more than 25% of the global population) by 2050. Amid this demographic shift, Africa faces a unique healthcare challengeânavigating a complex landscape of infectious and non-communicable diseases. This necessitates a departure from the conventional âone-size-fits-allâ medical model toward precision approaches that are efficient and sustainable. Genomic capacity is a pillar of precision health; however, access to up-to-date genetic testing in African countries is limited, compounded by a startling lack of representation of data from populations of African descent in gene discovery studies. In this Review, we delve into the challenges impeding the development of genomic capacity in Africa, such as the lack of electronic clinical and epidemiological records, infrastructural challenges, high supply chain costs and the âdependency trapâ that jeopardizes long-term sustainability. We emphasize the need for strategies hinged on true partnerships, robust infrastructure, workforce development and well-crafted policies. Finally, we outline recent progress and existing initiatives that should be considered as role models for future capacity-building initiatives.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
United Nations. World Population Prospects 2017. Department of Economic and Social Affairs, United Nations, New York, 1â47 (2017).
Bigna, J. J. & Noubiap, J. J. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Glob. Health 7, e1295âe1296 (2019).
Borecki, I. B. & Province, M. A. Linkage and association: basic concepts. Adv. Genet. 60, 51â74 (2008).
Beltrame, M. H., Rubel, M. A. & Tishkoff, S. A. Inferences of African evolutionary history from genomic data. Curr. Opin. Genet. Dev. 41, 159â166 (2016).
Fan, S. et al. Whole-genome sequencing reveals a complex African population demographic history and signatures of local adaptation. Cell 186, 923â939 (2023).
Tishkoff, S. A. et al. The genetic structure and history of Africans and African Americans. Science 324, 1035â1044 (2009).
Mills, M. C. & Rahal, C. The GWAS Diversity Monitor tracks diversity by disease in real time. Nat. Genet. 52, 242â243 (2020).
Fitipaldi, H. & Franks, P. W. Ethnic, gender and other sociodemographic biases in genome-wide association studies for the most burdensome non-communicable diseases: 2005â2022. Hum. Mol. Genet. 32, 520â532 (2023).
Olusanya, B. O., Neumann, K. J. & Saunders, J. E. The global burden of disabling hearing impairment: a call to action. Bull. World Health Organ. 92, 367â373 (2014).
Walls, W. D. & Azaiez, H. & Smith, R. Hereditary Hearing Loss Homepage. https://hereditaryhearingloss.org/ (accessed January 2024).
Del Castillo, F. J. & Del Castillo, I. DFNB1 non-syndromic hearing impairment: diversity of mutations and associated phenotypes. Front. Mol. Neurosci. 10, 428 (2017).
Chan, D. K. & Chang, K. W. GJB2-associated hearing loss: systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope 124, E34âE53 (2014).
Adhikary, B. et al. Spectrum and frequency of GJB2, GJB6 and SLC26A4 gene mutations among nonsyndromic hearing loss patients in eastern part of India. Gene 573, 239â245 (2015).
Wonkam, E. T. et al. GJB2 and GJB6 mutations in hereditary recessive non-syndromic hearing impairment in Cameroon. Genes 10, 844 (2019).
Wonkam, A., Manyisa, N., Bope, C. D., Dandara, C. & Chimusa, E. R. Whole exome sequencing reveals pathogenic variants in MYO3A, MYO15A and COL9A3 and differential frequencies in ancestral alleles in hearing impairment genes among individuals from Cameroon. Hum. Mol. Genet. 29, 3729â3743 (2020).
Wonkam, A. et al. Exome sequencing of families from Ghana reveals known and candidate hearing impairment genes. Commun. Biol. 5, 369 (2022).
World Health Organization. Fact sheet cancer. http://www.who.int/mediacentre/factsheets/fs297/en/ (2022).
International Agency for Research on Cancer, World Health Organization. Global Cancer Observatory, Fact sheet all cancers. Cancer Today, GLOBOCAN 149, 778â789 (2022).
Ansari-Pour, N. et al. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nat. Commun. 12, 6946 (2021).
Okoturo, E. Genetic determinants of cancers in Sub-Saharan African-based populations: a systematic review. Afr. J. Biomed. Res. 24, 311â317 (2021).
Rotimi, S. O., Rotimi, O. A. & Salhia, B. A review of cancer genetics and genomics studies in Africa. Front. Oncol. 10, 606400 (2021).
Thomson, A. M. et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000â2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 10, e585âe599 (2023).
Kato, G. J. et al. Sickle cell disease. Nat. Rev. Dis. Primers 4, 18010 (2018).
Luzzatto, L. Sickle cell anaemia and malaria. Mediterr. J. Hematol. Infect. Dis. 4, e2012065 (2012).
Rayner, B. L., Jones, E. S. W., Davidson, B. & Wearne, N. Advances in chronic kidney disease in Africa. Appl. Sci. 13, 4924 (2023).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841â845 (2010).
Hung, R. K. Y. et al. Genetic variants of APOL1 are major determinants of kidney failure in people of african ancestry with HIV. Kidney Int. Rep. 7, 786â796 (2022).
Pérez-Morga, D. et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469â472 (2005).
Vanhamme, L. et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83â87 (2003).
Niohuru, I. Healthcare and Disease Burden in Africa: The Impact of Socioeconomic Factors on Public Health (Springer, 2023).
de Silva, E. & Stumpf, M. P. H. HIV and the CCR5-Î32 resistance allele. FEMS Microbiol. Lett. 241, 1â12 (2004).
Novembre, J., Galvani, A. P. & Slatkin, M. The geographic spread of the CCR5 Î32 HIV-resistance allele. PLoS Biol. 3, e339 (2005).
Henrich, T. J. et al. Genome-wide association study of human immunodeficiency virus (HIV)-1 coreceptor usage in treatment-naive patients from an AIDS clinical trials group study. Open Forum Infect. Dis. 1, ofu018 (2014).
Boahen, C. K. et al. Genetic regulators of cytokine responses upon BCG vaccination in children from West Africa. J. Genet. Genomics 50, 434â446 (2023).
World Health Organization. Global Tuberculosis Report 2023. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023 (2023).
The White House Office of the Press Secretary. Fact Sheet: President Obamaâs Precision Medicine Initiative. https://obamawhitehouse.archives.gov/the-press-office/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative (2015).
UNESCO Institute for Statistics. Fact Sheet: Global investments in R&D (research and experimental development). 42, 1â8 (2017).
Simpkin, V., Namubiru-Mwaura, E., Clarke, L. & Mossialos, E. Investing in health R&D: where we are, what limits us, and how to make progress in africa. BMJ Glob. Health 4, e001047 (2019).
Staunton, C. et al. Safeguarding the future of genomic research in South Africa: broad consent and the protection of Personal Information Act no. 4 of 2013. South Afr. Med. J. 109, 468â470 (2019).
Chanda-Kapata, P., Kapata, N., Moraes, A. N., Chongwe, G. & Munthali, J. Genomic research in Zambia: confronting the ethics, policy and regulatory frontiers in the 21st century. Health Res. Policy Syst. 13, 60 (2015).
Nankya, H., Wamala, E., Alibu, V. P. & Barugahare, J. Community engagement in genetics and genomics research: a qualitative study of the perspectives of genetics and genomics researchers in Uganda. BMC Med. Ethics 25, 1 (2024).
Akwaowo, C. D. et al. Adoption of electronic medical records in developing countriesâa multi-state study of the Nigerian healthcare system. Front. Digit. Health 4, 1017231 (2022).
Zhang, H. L. et al. Challenges of maintaining good clinical laboratory practices in low-resource settings: a health program evaluation framework case study from East Africa. Am. J. Clin. Pathol. 146, 199â206 (2016).
Ashiwaju, B. I., Agho, M. O., Okogwu, C., Orikpete, O. F. & Daraojimba, C. Digital transformation in pharmaceutical supply chain: an African case. Matrix Science Pharma 7, 95â102 (2023).
Omotoso, O. E. et al. Bridging the genomic data gap in Africa: implications for global disease burdens. Global. Health 18, 103 (2022).
Fonjungo, P. N. et al. Laboratory equipment maintenance: a critical bottleneck for strengthening health systems in sub-Saharan Africa. J. Public Health Policy 33, 34â45 (2012).
De Maria, C., Mazzei, D. & Ahluwalia, A. Improving African healthcare through open source biomedical engineering. Int. J. Adv. Life Sci. 7, 10â19 (2015).
Akinyemi, R. O. et al. Biobanking in a challenging African environment: unique experience from the SIREN Project. Biopreserv. Biobank. 16, 217â232 (2018).
Stork, C. & Esselaar, S. Towards an African e-index: SME e-access and usage across 14 African countries. Research ICT Africa (2006).
Dalberg. Impact of the Internet in Africa. 5â50 http://www.impactoftheinternet.com/pdf/Dalberg_Impact_of_Internet_Africa_Full_Report_April2013_vENG_Final.pdf (2013).
Akintola, A. A., Hwang, U. W. & Aborode, A. T. Africa needs more bioinformaticians for population studies. Nature 605, 619 (2022).
Misau, Y. A., Al-Sadat, N. & Gerei, A. B. Brain-drain and health care delivery in developing countries. J. Public Health Afr. 1, 20â21 (2010).
World Bank. World Health Organizationâs Global Health Workforce Statistics Physicians (per 1,000 people). https://data.worldbank.org/indicator/SH.MED.PHYS.ZS (2024).
Maharaj, B. The African brain drain: causes, costs, consequences. Afr. Insight 40, 96â108 (2010).
Zhong, A. et al. Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: a systematic review. Genet. Med. 23, 2270â2280 (2021).
Hsu, L. et al. White paper: pathways to progress in newborn screening for sickle cell disease in Sub-Saharan Africa. J. Trop. Dis. Public Health 6, 260 (2018).
Abacan, M. A. et al. The global state of the genetic counseling profession. Eur. J. Hum. Genet. 27, 183â197 (2019).
Jongeneel, C. V. et al. A view on genomic medicine activities in Africa: implications for policy. Front. Genet. 13, 769919 (2022).
Fakiya, V. Electronic health and medical records can improve healthcare in Africa, but there are obstacles to their widespread adoption. https://techpoint.africa/2023/02/13/electronic-medical-health-records-africa/ (2013).
Medical Device Network. Setting an example: Rwanda as a digital health success story. https://www.medicaldevice-network.com/features/setting-an-example-rwanda-as-a-digital-health-success-story/?cf-view (2015).
Bowden, R. et al. Sequencing of human genomes with nanopore technology. Nat. Commun. 10, 1869 (2019).
Glanzmann, B. et al. Human whole genome sequencing in South Africa. Sci. Rep. 11, 606 (2021).
Croxton, T. et al. Building blocks for better biorepositories in Africa. Genome Med. 15, 92 (2023).
Agarwal, S., Kirrane, S. & Scharf, J. Modelling the general data protection regulation. in Internationales Rechtsinformatik Symposion (IRIS) (2017).
NHS. UK Genomics Education Programme. https://www.genomicseducation.hee.nhs.uk/ (2014).
The Global Alliance for Genomics and Health. The Global Alliance for Genomics and Health. https://www.ga4gh.org/ (2013).
Ihekweazu, C. et al. First African SARS-CoV-2 genome sequence from Nigerian COVID-19 case. Genome Rep. https://virological.org/t/first-african-sars-cov-2-genome-sequence-from-nigerian-covid-19-case/421 (2020).
ACEGID. ACEGID boosts genomics sequencing capacity with two new state-of-the-art sequencing machines. https://acegid.org/acegid-boosts-genomics-sequencing-capacity-with-two-new-sequencing-machines/ (2023).
Saied, A. A. et al. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. EMBO Mol. Med. 14, e16287 (2022).
South African Medical Research Council. SAMRC Genomics Platform. https://www.samrc.ac.za/services/genomic-centre/ (accessed April 2024).
Mulder, N. et al. H3Africa: current perspectives. Pharmacogenomics Pers. Med. 11, 59â66 (2018).
Acknowledgements
C.H.âs research is supported by The Rockefeller Foundation (grant no. 2021 HTH), TEDâs Audacious project (including the ELMA Foundation, MacKenzie Scott and the Skoll Foundation), The World Bank (projects ACE-019 and ACE-IMPACT), National Institute of Allergy and Infectious Diseases (grant no. U01HG007480) and NIHâs H3Africa (grant no. U54HG007480).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Medicine thanks Solomon Rotimi and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Karen OâLeary, in collaboration with the Nature Medicine team.
Additional information
Publisherâs note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Olono, A., Mitesser, V., Happi, A. et al. Building genomic capacity for precision health in Africa. Nat Med 30, 1856â1864 (2024). https://doi.org/10.1038/s41591-024-03081-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-03081-9